“‘Signed, sealed, delivered’: Pay-for-delay deals aren’t all bad”April 6, 2016
Partner Katherine L. Neville, Ph.D. was interviewed for the February 17, 2016 issue of IPPro Life Sciences. In the article “‘Signed, sealed, delivered’: Pay-for-delay deals aren’t all bad,” Dr. Neville discusses the effects and benefits of pay-for-delay deals in the pharmaceutical industry.
To read the full interview, click here.
For clients seeking patent protection in all areas of biotechnology and pharmaceuticals, Katherine L. Neville, Ph.D. delivers guidance to secure their inventions worldwide. She calls on her advanced studies in microbiology and immunology and over a decade of patent prosecution experience to advance their business goals. Her extensive experience includes patent preparation, opinions, and due diligence analyses for clients interested in partnering, and various patent proceedings, including interference, reexamination and opposition proceedings. Dr. Neville serves clients ranging from non-profit institutions to biotech start-ups to big pharma, and capably understands their diverse needs across a wide range of technologies.